- Home
- BEEM vs ENLV Comparison
BEEM vs ENLV Comparison
Compare BEEM & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- ENLV
- Stock Information
- Founded
- BEEM 2006
- ENLV 2005
- Country
- BEEM United States
- ENLV Israel
- Employees
- BEEM N/A
- ENLV N/A
- Industry
- BEEM Semiconductors
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- ENLV Health Care
- Exchange
- BEEM Nasdaq
- ENLV Nasdaq
- Market Cap
- BEEM 31.9M
- ENLV 26.6M
- IPO Year
- BEEM N/A
- ENLV 1995
- Fundamental
- Price
- BEEM $1.82
- ENLV $0.91
- Analyst Decision
- BEEM Strong Buy
- ENLV Buy
- Analyst Count
- BEEM 3
- ENLV 2
- Target Price
- BEEM $4.00
- ENLV $7.00
- AVG Volume (30 Days)
- BEEM 559.8K
- ENLV 10.9M
- Earning Date
- BEEM 11-14-2025
- ENLV 11-28-2025
- Dividend Yield
- BEEM N/A
- ENLV N/A
- EPS Growth
- BEEM N/A
- ENLV N/A
- EPS
- BEEM N/A
- ENLV N/A
- Revenue
- BEEM $27,668,000.00
- ENLV N/A
- Revenue This Year
- BEEM N/A
- ENLV N/A
- Revenue Next Year
- BEEM $45.38
- ENLV N/A
- P/E Ratio
- BEEM N/A
- ENLV N/A
- Revenue Growth
- BEEM N/A
- ENLV N/A
- 52 Week Low
- BEEM $1.33
- ENLV $0.83
- 52 Week High
- BEEM $4.23
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- BEEM 34.68
- ENLV 38.46
- Support Level
- BEEM $1.64
- ENLV $0.83
- Resistance Level
- BEEM $1.76
- ENLV $1.81
- Average True Range (ATR)
- BEEM 0.18
- ENLV 0.12
- MACD
- BEEM -0.00
- ENLV -0.00
- Stochastic Oscillator
- BEEM 24.91
- ENLV 7.64
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.